Patents by Inventor FREDERIC REYNARD

FREDERIC REYNARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FCV recombinant vaccines and uses thereof
    Patent number: 10434165
    Abstract: The present invention encompasses FCV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FCV antigens. The invention also encompasses recombinant vectors encoding and expressing FCV antigens, epitopes or immunogens which can be used to protect animals against FCV infection.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: October 8, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Herve Poulet, Frédéric Reynard
  • FMDV and E2 fusion proteins and uses thereof
    Patent number: 10363300
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: July 30, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • Newcastle disease virus vectored avian vaccines
    Patent number: 10350286
    Abstract: The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: July 16, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Michel Bublot, Frederic Reynard, François-Xavier Le Gros
  • FCV RECOMBINANT VACCINES AND USES THEREOF
    Publication number: 20180243399
    Abstract: The present invention encompasses FCV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FCV antigens. The invention also encompasses recombinant vectors encoding and expressing FCV antigens, epitopes or immunogens which can be used to protect animals against FCV infection.
    Type: Application
    Filed: August 16, 2016
    Publication date: August 30, 2018
    Applicant: MERIAL INC.
    Inventors: Herve Poulet, Frédéric Reynard
  • FMDV recombinant vaccines and uses thereof
    Patent number: 10010605
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: July 3, 2018
    Assignee: Merial, Inc.
    Inventors: Jean-Christophe Audonnet, Zahia Hannas-Djebbara, Teshome Mebatsion, Yu-Wei Chiang, Justin Widener, Frédéric Reynard
  • FMDV and E2 Fusion Proteins and Uses Thereof
    Publication number: 20180169216
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Application
    Filed: February 5, 2018
    Publication date: June 21, 2018
    Applicant: MERIAL INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • FMDV and E2 fusion proteins and uses thereof
    Patent number: 9913891
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: March 13, 2018
    Assignee: MERIAL INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • NEWCASTLE DISEASE VIRUS VECTORED AVIAN VACCINES
    Publication number: 20170224807
    Abstract: The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
    Type: Application
    Filed: February 16, 2017
    Publication date: August 10, 2017
    Applicant: Merial Inc.
    Inventors: Michel Bublot, Frederic REYNARD, François-Xavier LE GROS
  • FMDV and E2 Fusion Proteins and Uses Thereof
    Publication number: 20170143819
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV. The invention further encompasses methods of making or producing antigenic polypeptides or antigens.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 25, 2017
    Applicant: MERIAL INC.
    Inventors: Jean-Christophe Audonnet, Frédéric Reynard, Natalia Bomchil, Cécile Sigoillot-Claude
  • Newcastle disease virus vectored avian vaccines
    Patent number: 9616118
    Abstract: The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: April 11, 2017
    Assignee: MERIAL, INC.
    Inventors: Michel Bublot, Frederic Reynard, François-Xavier Le Gros
  • Newcastle disease virus vectored herpesvirus vaccines
    Patent number: 9446118
    Abstract: The present invention encompasses recombinant Newcastle Disease Virus-Herpesvirus vaccines or compositions. The invention encompasses recombinant NDV vectors encoding and expressing herpesvirus pathogen, antigens, proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals against disease.
    Type: Grant
    Filed: February 6, 2015
    Date of Patent: September 20, 2016
    Assignee: Merial, Inc.
    Inventors: Michel Bublot, Frederic Reynard, Herve Poulet, Frederic Raymond David
  • FMDV RECOMBINANT VACCINES AND USES THEREOF
    Publication number: 20160220659
    Abstract: The present invention encompasses FMDV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing FMDV antigens. The invention also encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Application
    Filed: September 23, 2015
    Publication date: August 4, 2016
    Applicant: MERIAL, INC.
    Inventors: Jean-Christophe Audonnet, Zahia Hannas-Djebbara, Teshome Mebatsion, Yu-Wei Chiang, Justin Widener, Frédéric Reynard
  • Newcastle Disease Virus Vectored Herpesvirus Vaccines
    Publication number: 20150157704
    Abstract: The present invention encompasses recombinant Newcastle Disease Virus-Herpesvirus vaccines or compositions. The invention encompasses recombinant NDV vectors encoding and expressing herpesvirus pathogen, antigens, proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals against disease.
    Type: Application
    Filed: February 6, 2015
    Publication date: June 11, 2015
    Applicant: MERIAL LIMITED
    Inventors: Michel Bublot, Frederic Reynard, Herve Poulet, Frederic Raymond David
  • Newcastle disease virus vectored herpesvirus vaccines
    Patent number: 8986706
    Abstract: The present invention encompasses recombinant Newcastle Disease Virus-Herpesvirus vaccines or compositions. The invention encompasses recombinant NDV vectors encoding and expressing herpesvirus pathogen, antigens, proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals against disease.
    Type: Grant
    Filed: August 29, 2011
    Date of Patent: March 24, 2015
    Assignee: Merial, Inc.
    Inventors: Michel Bublot, Frederic Reynard, Herve Poulet, Frederic Raymond David
  • Newcastle disease virus vectored avian vaccines
    Patent number: 8871220
    Abstract: The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
    Type: Grant
    Filed: April 2, 2010
    Date of Patent: October 28, 2014
    Assignee: Merial Limited
    Inventors: Michel Bublot, Frederic Reynard, François-Xavier Le Gros
  • NEWCASTLE DISEASE VIRUS VECTORED AVIAN VACCINES
    Publication number: 20140234358
    Abstract: The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
    Type: Application
    Filed: May 2, 2014
    Publication date: August 21, 2014
    Applicant: MERIAL LIMITED
    Inventors: Michel Bublot, Frederic REYNARD, François-Xavier LE GROS
  • NEWCASTLE DISEASE VIRUS VECTORED AVIAN VACCINES
    Publication number: 20100255029
    Abstract: The present invention encompasses engineered Newcastle Disease Virus (NDV) vaccines or compositions. The vaccine or composition may be a recombinant vaccine. The invention also encompasses recombinant vectors encoding and expressing avian pathogen antigens, more specifically avian influenza proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals, in particular avian, against disease.
    Type: Application
    Filed: April 2, 2010
    Publication date: October 7, 2010
    Inventors: MICHEL BUBLOT, FRANÇOIS-XAVIER LE GROS, FREDERIC REYNARD